Xiaoshi Wang
CDER, FDA
Dr. Xiaoshi Wang is product quality assessor on protein therapeutics at FDA/CDER/OPQ/OBP. She was ORISE fellow at FDA/CDER/OPQ/OTR developing mass spectrometry-based methods for the analysis of biotherapeutic products and peptide drugs. Before she joined FDA, she was scientist at Novavax working on vaccine development and post-doc at University of Pennsylvania working on quantitative proteomics. Dr. Wang received her Ph.D. degree in Chemistry from Princeton University.